A recent RNA-Seq study of acute myeloid leukemia patients at remission identified an aberrant RNA splicing of exon3-skipping event in TRIP12 suggesting future investigation of its use as a potential target [44]. Here, TRIP12 is linked to acute myeloid leukemia.